IN8bio Inc
INAB
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.67M
Close$
$5.56
260.9% upside
Current Fair Value
260.9% upsideUndervalued by 260.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.67 Million |
|---|---|
| Enterprise Value | $-10,918,991.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.44 |
| Beta | 0.08 |
| Outstanding Shares | 4,374,328 |
Return
| Return on Equity | -83.32% |
|---|---|
| Return on Assets | -72.26% |
| Return on Invested Capital | -77.83% |
Valuation & Multiples
| P/E Ratio | -0.43 |
|---|---|
| PEG | 5.2 |
| Price to Sales | - |
| Price to Book Ratio | 0.31 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.58 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.22 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 7, 2026
EPS Estimate
$-0.59
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.34
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 85.79%▲ 12.00% |
|---|---|
| Total Invested | $5.55M▼ 25.45% |
| Investors Holding | 19▼ 3.00% |
ESG Score
No data
About IN8bio Inc
7 employees
CEO: William Ho